Sign In
Buy BNTX
$91.35
-0.90 (-0.98%)
At Close: Aug 04, 2026
A Peek Into The Markets: US Stock Futures Down Ahead Of GDP Report
10:05am, Wednesday, 30'th Mar 2022 Benzinga
Pre-open movers
U.S. stock futures traded lower in early pre-market trade after the Dow Jones jumped more than 300 points in the previous session. Investors are awaiting earnings results from Five Be
BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
10:00am, Wednesday, 30'th Mar 2022 GlobeNewswire Inc.
Conference call and webcast scheduled for March 30, 2022 at 8:00 am ET (2:00 pm CET)
BioNTech veröffentlicht Ergebnisse für das vierte Quartal und das Geschäftsjahr 2021 sowie Informationen zur Geschäftsentwicklung
10:00am, Wednesday, 30'th Mar 2022 GlobeNewswire Inc.
Telefonkonferenz und Webcast sind für den 30. März 2022 um 14 Uhr MEZ geplant
BioNTech reports unbelievable YoY growth for its fiscal Q4
09:51am, Wednesday, 30'th Mar 2022
BioNTech SE shares (NASDAQ: BNTX) opened 8% up on Wednesday after the pharmaceutical company handily beat Street expectations for Q4 earnings and revenue. Notable figures in BioNTech Q4 earnings repor
Why BioNTech Shares Are Surging Today
09:20am, Wednesday, 30'th Mar 2022
BioNTech SE (NASDAQ: BNTX) reported Q4 FY21 revenues of €5.53 billion compared to €345.4 million a year ago, mainly due to high demand for the company's COVID-19 vaccine. BioNTech and its partn
Dow Jones Newswires: BioNTech reports soaring earnings, revenue on COVID vaccine, plans $1.5 billion in buybacks
06:43am, Wednesday, 30'th Mar 2022
German pharmaceutical company BioNTech SE reported soaring earnings and revenue for the fourth quarter, driven by the Covid-19 vaccine it produces with Pfizer Inc, and said it is starting a share buyb
BioNTech's Earnings Top Estimates. It Plans a Buyback and Special Dividend.
06:16am, Wednesday, 30'th Mar 2022
BioNTech says it plans to buy back up to $1.5 billion of stock over the next two years. It also will propose to pay a special dividend of €2 a share.
Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
11:31pm, Tuesday, 29'th Mar 2022
Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
Why Moderna and BioNTech Were Winners Today
10:07pm, Tuesday, 29'th Mar 2022 The Motley Fool
The FDA expands its authorization for both companies' coronavirus vaccines.
Why Moderna and BioNTech Were Winners Today
06:07pm, Tuesday, 29'th Mar 2022
The FDA expands its authorization for both companies' coronavirus vaccines.
FDA Authorizes Fourth Dose Of Moderna, Pfizer/BioNTech COVID-19 Vaccines For Older People
01:22pm, Tuesday, 29'th Mar 2022
The FDA has approved a second round of the Moderna Inc (NASDAQ: MRNA) or Pfizer Inc (NYSE: PFE), and BioNTech SE (NASDAQ: BNTX) COVID-19 vaccines for older people and certain immunocompromise
FDA authorizes fourth Covid vaccine dose for people age 50 and older
11:36am, Tuesday, 29'th Mar 2022
The U.S. Food and Drug Administration has authorized another Covid-19 vaccine dose from Pfizer and Moderna for everyone age 50 and older, as well as some immunocompromised patients. CNBC's Meg Tirrell
Earnings Previews: BioNTech, Chewy, Lululemon, Micron
10:58am, Tuesday, 29'th Mar 2022
Markets were off to a positive start on Tuesday, with the Nasdaq leading the charge with a gain of just over 1%.
Are These 2 Rivals Beating Pfizer and Moderna?
10:00am, Monday, 28'th Mar 2022 The Motley Fool
They're winning when it comes to orders.
BioNTech, Chewy, Lululemon, Walgreens, and Other Stocks to Watch
08:07am, Monday, 28'th Mar 2022
Chewy, Micron, Walgreens, Lululemon, and BioNTech release results this week. Plus, the March jobs report, February personal income and expenditures, and more economic data.
